Novartis CEO Calms Concerns Over Zolgensma launch

 
• By Kevin Grogan

The Swiss major has posted a strong set of financials for the second quarter and Vas Narasimhan is pleased with the roll-out of Zolgensma, Mayzent and Piqray.

Launch
Three key launches have gone as planned, the Swiss major claims • Source: Shutterstock

More from New Products

More from Scrip